Relevance of urinary interferon-gamma in the prognosis of superficial bladder cancer treated with BCG immunotherapy

被引：0
|
作者：
Zoumpos, I.
Touloupidis, S.
Giakoumelos, A.
Galaktidou, T.
Kortsaris, A.
Simopoulos, K.
Katsikas, V.
机构：
[1] Aristotle Univ Thessaloniki, Dept Urol 2, GR-54006 Thessaloniki, Greece
[2] Democritus Univ Thrace, Dept Urol, Alexandroupolis, Greece
[3] Theageneion Hosp, Dept Virol, Thessaloniki, Greece
[4] Democritus Univ Thrace, Dept Biochem, Alexandroupolis, Greece
[5] Democritus Univ Thrace, Dept Surg 2, Alexandroupolis, Greece
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2007年 / 6卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(07)60494-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [21] DIFFERENCES IN MACROPHAGE ACTIVATION BY BCG AND INTERFERON-GAMMA
    VANFURTH, R
    VANDISSEL, JT
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 400 - 400
  • [22] The use of BCG in superficial carcinoma of the urinary bladder
    Böhle, A
    Durek, C
    UROLOGE A, 2001, 40 (05): : 403 - 409
  • [23] RATIONALE FOR RECOMBINANT HUMAN INTERFERON-GAMMA ADJUVANT IMMUNOTHERAPY FOR CANCER
    JAFFE, HS
    HERBERMAN, RB
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (09) : 616 - 618
  • [24] Interferon-gamma in Brain Tumor Immunotherapy
    Kane, Ari
    Yang, Isaac
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2010, 21 (01) : 77 - +
  • [25] Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-γ
    Arnold, J
    de Boer, EC
    O'Donnell, MA
    Böhle, A
    Brandau, S
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (02) : 116 - 123
  • [26] BCG in Bladder Cancer Immunotherapy
    Jiang, Song
    Redelman-Sidi, Gil
    CANCERS, 2022, 14 (13)
  • [27] Specific features of BCG-therapy in management of superficial cancer of the urinary bladder
    Chepurov, AK
    Murshudli, EC
    Mazo, EB
    TERAPEVTICHESKII ARKHIV, 2002, 74 (10) : 70 - 72
  • [28] Immunotherapy for superficial bladder cancer
    Schenk-Braat, EAM
    Bangma, CH
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (05) : 414 - 423
  • [29] Immunotherapy for superficial bladder cancer
    Ellen A. M. Schenk-Braat
    Chris H. Bangma
    Cancer Immunology, Immunotherapy, 2005, 54 : 414 - 423
  • [30] Nearly fatal complications of cervical lymphadenitis following BCG immunotherapy for superficial bladder cancer
    Geldmacher, H
    Taube, C
    Markert, U
    Kirsten, DK
    RESPIRATION, 2001, 68 (04) : 420 - 421
12345